Pfizer: AIDS-Related Opportunistic Infections trials

The registry lists 15 AIDS-Related Opportunistic Infections studies with Pfizer as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 3 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin BCompletedNCT00002306Not applicable
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal MeningitisCompletedNCT00002305Not applicable
• A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002304Not applicable
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDSCompletedNCT00002294Not applicable
• A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDSCompletedNCT00002282Not applicable
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled TrialCompletedNCT00002267Not applicable
• An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002077Not applicable
• Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002076Not applicable
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002075Not applicable
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency SyndromeCompletedNCT00002074Not applicable
• A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002068Not applicable
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002040Not applicable
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled TrialCompletedNCT00002032Not applicable
• Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal MeningitisCompletedNCT00002010Not applicable
• Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDSCompletedNCT00001017Phase 3